December 26, 2020
That is the implication of a major piece on how the coronavirus vaccines are leading to greater worldwide inequality since rich countries have reserved the vast majority of the 2021 supplies of the leading U.S.-European vaccines. While this is, in fact, a serious problem, as my co-authors and I have noted, China also has produced several effective vaccines and is distributing them to developing countries.
China has already made commitments to supply hundreds of millions of doses to Brazil, Morocco, Indonesia, and other developing countries. While it would be best if every country with manufacturing capacity could produce any vaccine, without regard to intellectual property rules, it is bizarre that a piece on access to vaccines in the developing world would fail to mention the vaccines developed by China.